Pharmacokinetic and Pharmacodynamic Comparison of Two Formulations of a Fixed-Dose Combination of Gemigliptin/Rosuvastatin 50/20 mg: A Randomized, Open-Label, Single-Dose, Two-Way Crossover Study

Pharmacokinetic and Pharmacodynamic Comparison of Two Formulations of a Fixed-Dose Combination of Gemigliptin/Rosuvastatin 50/20 mg: A Randomized, Open-Label, Single-Dose, Two-Way Crossover Study

Eunsol Yang, Hyounggyoon Yoo, In-Jin Jang, Kyung-Sang Yu, SeungHwan Lee Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of KoreaCorrespondence: SeungHwan LeeDepartment of Clinical Pharmacology and Therapeutics, Seoul N...

Full description

Bibliographic Details
Main Authors: Yang E, Yoo H, Jang IJ, Yu KS, Lee S
Format: Article
Language:English
Published: Dove Medical Press 2021-02-01
Series:Drug Design, Development and Therapy
Subjects:
dpp-4 inhibitor
statin
type 2 diabetes
dyslipidemia
bioequivalence
Online Access:https://www.dovepress.com/pharmacokinetic-and-pharmacodynamic-comparison-of-two-formulations-of--peer-reviewed-article-DDDT

Similar Items

Similar Items